Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T S Lamberg

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacology & Toxicology|March 6, 1999
Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspironeK T Kivistö, T S Lamberg, P J Neuvonen
Clinical Pharmacology and Therapeutics|July 15, 1998
Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspironeT S Lamberg, K T Kivistö, P J Neuvonen
British Journal of Clinical Pharmacology|May 13, 1998
Concentrations and effects of buspirone are considerably reduced by rifampicinT S Lamberg, K T Kivistö, P J Neuvonen
Pharmacology & Toxicology|May 5, 1999
Lack of effect of terfenadine on the pharmacokinetics of the CYP3A4 substrate buspironeT S Lamberg, K T Kivistö, P J Neuvonen
Clinical Pharmacology and Therapeutics|October 23, 1997
Plasma buspirone concentrations are greatly increased by erythromycin and itraconazoleK T Kivistö, T S Lamberg, T Kantola, et al.
British Journal of Clinical Pharmacology|May 1, 1997
Concentrations and effects of zopiclone are greatly reduced by rifampicinK Villikka, K T Kivistö, T S Lamberg, et al.
European Journal of Clinical Pharmacology|January 29, 1999
The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspironeT S Lamberg, K T Kivistö, J Laitila, et al.
Clinical Pharmacology and Therapeutics|January 1, 1999
Grapefruit juice substantially increases plasma concentrations of buspironeJ J Lilja, K T Kivistö, J T Backman, et al.
British Journal of Anaesthesia|January 1, 1995
Auditory disturbance associated with interscalene brachial plexus blockP H Rosenberg, T S Lamberg, P Tarkkila, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacology & Toxicology|March 6, 1999
Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspironeK T Kivistö, T S Lamberg, P J Neuvonen
Clinical Pharmacology and Therapeutics|July 15, 1998
Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspironeT S Lamberg, K T Kivistö, P J Neuvonen
British Journal of Clinical Pharmacology|May 13, 1998
Concentrations and effects of buspirone are considerably reduced by rifampicinT S Lamberg, K T Kivistö, P J Neuvonen
Pharmacology & Toxicology|May 5, 1999
Lack of effect of terfenadine on the pharmacokinetics of the CYP3A4 substrate buspironeT S Lamberg, K T Kivistö, P J Neuvonen
Clinical Pharmacology and Therapeutics|October 23, 1997
Plasma buspirone concentrations are greatly increased by erythromycin and itraconazoleK T Kivistö, T S Lamberg, T Kantola, et al.
British Journal of Clinical Pharmacology|May 1, 1997
Concentrations and effects of zopiclone are greatly reduced by rifampicinK Villikka, K T Kivistö, T S Lamberg, et al.
European Journal of Clinical Pharmacology|January 29, 1999
The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspironeT S Lamberg, K T Kivistö, J Laitila, et al.
Clinical Pharmacology and Therapeutics|January 1, 1999
Grapefruit juice substantially increases plasma concentrations of buspironeJ J Lilja, K T Kivistö, J T Backman, et al.
British Journal of Anaesthesia|January 1, 1995
Auditory disturbance associated with interscalene brachial plexus blockP H Rosenberg, T S Lamberg, P Tarkkila, et al.
Pageof 1